Angiographic considerations in patients undergoing liver-directed therapy

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 7, 2005, Pages 911-935

  Liu, David M ^a   Salem, Riad ^b,f   Bui, James T ^c   Courtney, Angi ^b   Barakat, Omar ^b   Sergie, Ziad ^d   Atassi, Basel ^b   Barrett, Karen ^b   Gowland, Patricia ^b   Oman, Beth ^e   Lewandowski, Robert J ^b   Gates, Vanessa L ^b   Thurston, Kenneth G ^f   Wong, Ching Yee O ^e  

^a St Vincent's Hospital   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f Department of Radiology ^*

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; SIR SPHERE; TECHNETIUM 99M; THERASPHERE; YTTRIUM 90;

ARTIFICIAL EMBOLISM; BRACHYTHERAPY; CATHETERIZATION; DRUG COATING; DRUG DELIVERY SYSTEM; HEPATIC ARTERY; HUMAN; INFUSION PUMP; LIVER ANGIOGRAPHY; LIVER CIRCULATION; LIVER PERFUSION; LIVER TUMOR; MESENTERIC ARTERY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REVIEW; SURGICAL TECHNIQUE;

EID: 22244468074     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000164324.79242.B2     Document Type: Review

References (113)

1. Ottery FD, Scupham RK, Weese JL. Chemical cholecystitis after intrahepatic chemotherapy: the case for prophylactic cholecystectomy during pump placement. Dis Colon Rectum 1986; 29:187-190.
2. Wollner I, Knutsen C, Smith P, et al. Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 1988; 61:1336-1344.
3. Skitzki JJ, Chang AE. Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 2002; 11:123-135.
4. Williams DM, Cho KJ, Ensminger WD, Ziessman HA, Gyves JW. Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance. Radiology 1985; 156:339-340.
5. Daly JM, Kemeny N, Oderman P, Botet J. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg 1984; 119:936-941.
6. Allen PJ, Stojadinovic A, Ben-Porat L, et al. The management of variant arterial anatomy during hepatic arterial infusion pump placement. Ann Surg Oncol 2002; 9:875-880.
7. Kemeny MM. The surgical aspects of the totally implantable hepatic artery infusion pump. Arch Surg 2001; 136:348-352.
8. Campbell KA, Burns RC, Sitzmann JV, Lipsett PA, Grochow LB, Niederhuber JE. Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol 1993; 11:822-826.
9. Fleischmann D. MDCT of renal and mesenteric vessels. Eur Radiol 2003; 13(suppl 5):M94-M101.
10. Marymont JV, Dakhil SR, Travers H, Housholder DF. Chemical cholecystitis associated with hepatic arterial chemotherapy delivered by a permanently implanted pump. Hum Pathol 1985; 16:986-990.
11. Koukourakis MI. Tumour angiogenesis and response to radiotherapy. Anticancer Res 2001; 21:4285-4300.
12. Das U. A radical approach to cancer. Med Sci Monit 2002; 8:RA79-RA92.
13. Hashimoto LA, Ouchi K, Matsuno S. Transcatheter arterial embolization and chemoembolization induce the production of free radicals in the normal rat liver. Res Exp Med (Berl) 1990; 90:259-265.
14. Konno T. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 1990; 66:1897-1903.
15. Brown KT, Nevins AB, Getrajdman GI, et al. Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 1998; 9:822-828.
16. Brown KT, Koh BY, Brody LA, et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 1999; 10:397-403.
17. Llovet JM, Real MI, Montana X, et al. for the Barcelona Liver Cancer Group. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739.
18. Sullivan RD, Watkins E Jr, Zurek WZ. Cancer chemotherapy by prolonged ambulatory arterial infusion. Proc Natl Cancer Conf 1964; 5:543-559.
19. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 1987; 59:1547-1553.
20. Johnson PT, Heath DG, Kuszyk BS, Fishman EK. CT angiography with volume rendering: advantages and applications in splanchnic vascular imaging. Radiology 1996; 200:564-568.
21. Kuhns LR, Borlaza G. Normal roentgen variant: aberrant right hepatic artery on computed tomography. Radiology 1980; 135:392.
22. Hiwatashi A, Yoshida K. The origin of right inferior phrenic artery on multidetector row helical CT. Clin Imaging 2003; 27:298-303.
23. Carr BI. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Hepatogastroenterology 2002; 49:79-86.
24. Chun HJ, Byun JY, Yoo SS, Choi BG. Added benefit of thoracic aortography after transarterial embolization in patients with hemoptysis. AJR Am J Roentgenol 2003; 180:1577-1581.
25. Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198:33-40.
26. Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 2001; 12:957-963.
27. Ueno K, Miyazono N, Inoue H, Miyake S, Nishida H, Nakajo M. Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 1995; 18:183-185.
28. Arora R, Soulen MC, Haskal ZJ. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol 1999; 10: 1351-1356.
29. Price P, Holden C. Anatomic variance in the cholecystic blood supply: a case report. Am Surg 1993; 59:278-280.
30. Coin J, Dancey J, Roberts C, Sickles C, Leung D, Soulen M. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: transcatheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 2004; 3:49-56.
31. Daseler EH, Anson BJ, Hambley WC, Riemann AF. The cystic artery and constituents of the hepatic pedicle: a study of 500 specimens. Surg Gynecol Obstet 1947; 85:47-63.
32. Anson BJ. Anatomical considerations in surgery of the gallbladder. J Mich State Med Soc 1956; 55:671-672.
33. Sarkar AK, Roy TS. Anatomy of the cystic artery arising from the gastroduodenal artery and its choledochal branch-a case report. J Anat 2000; 197:503-506.
34. Chen WJ, Ying DJ, Liu ZJ, He ZP. Analysis of the arterial supply of the extrahepatic bile ducts and its clinical significance. Clin Anat 1999; 12:245-249.
35. Miyayama S, Matsui O, Nishida H, et al. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 2003; 14: 1155-1161.
36. Kim HK, Chung YH, Song BC, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 2001; 32:423-427.
37. Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12:313-320.
38. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12: 965-968.
39. Abe S, Yamasaki T, Nakano K, Yoshikawa I, Tabaru A, Otsuki M. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS. J Gastroenterol 2001; 36:415-421.
40. Woojin K, Clark TWI, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12:965-968.
41. VanDamme JP, Bonte J. Vascular anatomy in abdominal surgery. New York: Thieme, 1990.
42. Yamagami T, Nakamura T, Iida S, Kato T, Nishimura T. Embolization of the right gastric artery before hepatic arterial infusion chemotherapy to prevent gastric mucosal lesions: approach through the hepatic artery versus the left gastric artery. AJR Am J Roentgenol 2002; 179:1605-1610.
43. Nakamura H, Hashimoto T, Oi H, Sawada S, Furui S. Prevention of gastric complications in hepatic arterial chemoembolization: balloon catheter occlusion technique. Acta Radiol 1991; 32:81-82.
44. Hashimoto M, Heianna J, Tate E, Kurosawa R, Nishii TJ Mayama I. The feasibility of retrograde catheterization of the right gastric artery via the left gastric artery. J Vasc Interv Radiol 2001; 12:1103-1106.
45. Song SY, Chung JW, Kwon JW, et al. Collateral pathways in patients with celiac axis stenosis: angiographic-spiral CT correlation. Radiographics 2002; 22:881-893.
46. Hentati N, Fournier HD, Papon X, Aube C, Vialle R, Mercier P. Arterial supply of the duodenal bulb: an anatomoclinical study. Surg Radiol Anat 1999; 21:159-164.
47. VanDamme JP, Van der Schueren G, Bonte J. Vascularisation du pancreas: proposition de nomenclature PNA et angioarchitecture des ilots. C R Assoc Anat 1968; 139:1184-1192.
48. Carr BI, Zajko A, Bron K, Orons P, Sammon J, Baron R. Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis. Semin Oncol 1997; 24(suppl 6):S6J-S97.
49. Choplin RH, Gelfand DW, Hunt TH. Gastric perforation from hepatic artery infusion chemotherapy. Gastrointest Radiol 1983; 8:133-134.
50. Wilkie DP. The blood supply to the duodenum with special reference to the supra-duodenal artery. Surg Gynecol Obstet 1911; 13:399-405.
51. Bianchi HF, Albanese EF. The supraduodenal artery. Surg Radiol Anat 1989; 11:37-40.
52. Wind P, Chevallier JM, Sarcy JJ, Delmas V, Cugnenc PH. The infrapyloric artery and cephalic pancreatoduodenectomy with pylorus preservation: preliminary study. Surg Radiol Anat 1994; 16:165-172.
53. Kwon JW, Chung JW, Song SY, et al. Transcatheter arterial chemoembolization for hepatocellular carcinomas in patients with celiac axis occlusion. J Vasc Interv Radiol 2002; 13:689-694.
54. Hori S, Inoue E, Narumi Y, Fujita M, Kadowaki K. Hepatic arterial embolization in cases of extensive celiac arterial stenosis. Radiology 1991; 178: 353-355.
55. Okazaki M, Higashihara H, Ono H, et al. Chemoembolization for hepatocellular carcinoma via the inferior pancreaticoduodenal artery in patients with celiac artery stenosis. Acta Radiol 1993; 34:20-25.
56. Baba Y, Miyazono N, Ueno K, et al. Hepatic falciform artery: angiographic findings in 25 patients. Acta Radiol 2000; 41:329-333.
57. Kim DE, Yoon HK, Ko GY, Kwon JS, Song HY, Sung KB. Hepatic falciform artery: is prophylactic embolization needed before short-term hepatic arterial chemoinfusion? AJR Am J Roentgenol 1999; 172:1597-1599.
58. Gibo M, Hasuo K, Inoue A, Miura N, Murata S. Hepatic falciform artery: angiographic observations and significance. Abdom Imaging 2001; 26:515-519.
59. Ibukuro K, Tsukiyama T, Mori K, Inoue Y. Hepatic falciform ligament artery: angiographic anatomy and clinical importance. Surg Radiol Anat 1998; 20:367-371.
60. Chung JW, Park JH. Transcatheter arterial chemoembolization of hepatocelluar carcinoma. Bombay Hospital J 2002; 44:11.
61. Michels NA. Collateral pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer 1955; 6:708-724.
62. Manso JC, DiDio LJ. Anatomical variations of the human suprarenal arteries. Ann Anat 2000; 182:483-488.
63. Redd DC, Soulen MC, Crooks GW. Bilateral adrenal hemorrhage resulting in acute adrenal insufficiency as an unusual complication of hepatic arterial chemoembolization. J Vasc Interv Radiol 1998; 9:271-274.
64. Michels N. Blood supply and anatomy of the upper abdominal organs with a descriptive atlas. Philadelphia: JB Lippincott, 1955.
65. Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 2002; 224:542-547.
66. Gruttadauria S, Foglieni CS, Doria C, Luca A, Lauro A, Marino IR. The hepatic artery in liver transplantation and surgery: vascular anomalies in 701 cases. Clin Transplant 2001; 15: 359-363.
67. Varotti G, Gondolesi GE, Goldman J, et al. Anatomic variations in right liver living donors. J Am Coll Surg 2004; 198:577-582.
68. Jones RM, Hardy KJ. The hepatic artery: a reminder of surgical anatomy. J R Coll Surg Edinb 2001; 46:168-170.
69. Michels NA. The ever varied blood supply of the liver and its collateral circulation. J Int Coll Surg 1957; 27:1-17.
70. Erbay N, Raptopoulos V, Pomfret EA, Kamel IR, Kruskal JB. Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol 2003; 181:109-114.
71. Hentati N, Pasco A, Fournier HD, Papon X, Mercier P. Double hepatomesenteric artery: a rare anatomical variant. Surg Radiol Anat 2001; 23:285-289.
72. Legge D. The use of prostaglandin F2-alpha in selective pancreatic and left gastric angiography. Clin Radiol 1978; 29:285-288.
73. Mihas AA, Laws HL, Jander HP. Surgical treatment of the celiac axis compression syndrome. Am J Surg 1977; 133:688-691.
74. Pajdo R, Brzozowski T, Konrurek PC, et al. Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur J Pharmacol 2001; 427:263-276.
75. Bledin AG, Kantarjian HM, Kim EE, et al. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. AJR Am J Roentgenol 1982; 139:711-715.
76. Ngan H, Peh WC. Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol 1997; 52:36-40.
77. Bledin AG, Kim EE, Chuang VP, Wallace S, Haynie TP. Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium 99m macroaggregated albumin. Br J Radiol 1984; 57:197-203.
78. Okuda K, Musha H, Yamasaki T, et al. Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology 1977; 122:53-58.
79. Uraki J, Yamakado K, Nakatsuka A, Takeda K. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 2004; 51: 12-18.
80. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79:2087-2094.
81. Salem R, Lewandowski R, Roberts C, et al. Use of yttrium 90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004; 15:335-345.
82. Furuse J, Iwasaki M, Yoshino M, et al. Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 1997; 204:787-790.
83. Kwok PC, Lam TW, Lam CL, Lai AK, Lo HY, Chan SC. Rare pulmonary complications after transarterial chemoembolisation for hepatocellular carcinoma: two case reports. Hong Kong Med J 2003; 9:457-460.
84. Wachsberg RH, Bahramipour P, Sofocleous CT, Barone A. Hepatofugal flow in the portal venous system: pathophysiology, imaging findings, and diagnostic pitfalls. Radiographics 2002; 22:123-140.
85. Kan Z, Ivancev K, Lunderquist A. Peribiliary plexa-important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein: an experimental study in rats. Invest Radiol 1994; 29:671-676.
86. Lin M. Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings. AJR Am J Roentgenol 1994; 162:1300-1302.
87. Walser RH, Haldemann AR, Rosler H, Koranda P, Kinser JA, Triller J. Diagnostic angioscintigraphic evaluation of malignant hepatic tumors before catheter embolization: determination of shunt, flow distribution, and reflux. Cardiovasc Intervent Radiol 1996; 19: 77-81.
88. Leung TWT, Lau WY, Ho SKW, et al. Radiation pneumonitis after selective internal radiation treatment with intra-arterial 90-yttrium-microspheres for inoperable hepatic tumors. Int J Radiation Biol Phys 1995; 33:919-924.
89. Zelenock GB, Graham LM, Whitehouse WM Jr, et al. Splanchnic arteriosclerotic disease and intestinal angina. Arch Surg 1980; 115:497-501.
90. Park CM, Chung JW, Kim HB, Shin SJ, Park JH. Celiac axis stenosis: incidence and etiologies in asymptomatic individuals. Korean J Radiol 2001; 2:8-13.
91. Ogata T, Okuda K, Nagashima J, et al. Palmaz-Schatz stent for hepatic artery stenosis during hepatic arterial infusion chemotherapy. Hepatogastroenterology 1999; 46:2551-2553.
92. Golden MA, Vaughn DJ, Crooks GW, Holland GA, Bavaria JE. Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease-a case report. Angiology 1997; 48:1063-1065.
93. Belli L, Magistretti G, Puricelli GP, Damiani G, Colombo E, Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol 1997; 7:323-326.
94. Yoon DY, Park JH, Chung JW, Han JK, Han MC. Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients. Cardiovasc Intervent Radiol 1995; 18:16-19.
95. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13(suppl):S211-S221.
96. Hall JT, Kim EE, Charnsangavej C, Wallace S, Haynie TP. Variable patterns of technetium-99m MAA perfusion in the therapeutically embolized liver. J Nucl Med 1989; 30:1012-1017.
97. Sudoh M, Kishimoto Y, Marumoto A, et al. A new animal model of continuous catheterization for investigating mechanisms of arteritis associated with chemotherapy. Life Sci 2004; 74: 3025-3032.
98. Koelher RE, Korobkin M, Lewis F. Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology 1975; 94:575-579.
99. Rayner AA, Kerlan RK, Stagg RJ, Price DC, Hohn DC. Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapy. Surgery 1986; 99:708-715.
100. Cohen AM, Higgins J, Waltman AC, Athanasoulis C, McKusick K. Effect of ligation of variant hepatic arterial structures on the completeness of regional chemotherapy infusion. Am J Surg 1987; 153:378-380.
101. Kiyosue H, Matsumoto S, Hori Y, Okahara M, Sagara Y, Mori H. Turnback technique with use of a shaped microcatheter for superselective catheterization of arteries originating at acute angles. J Vasc Interv Radiol 2004; 15:641-643.
102. Kan Z, Wright K, Wallace S. Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad Radiol 1997; 4:275-282.
103. Hihara T, Araki T, Kachi K, Monzawa S, Uchiyama G. Dense parenchymal accumulation of Lipiodol after transarterial chemoembolization. Radiat Med 1992; 10:79-81.
104. Russel JLJ, Carden JL, Herron HL. Dosimetry calculations for Yttrium-90 used in the treatment of liver cancer. Endocuriether Hyperthermia Oncol 1988; 4:171-186.
105. Stribley KV, Gray BN, Chmiel RL, Heggie JC, Bennett RC. Internal radiotherapy for hepatic metastases I: the homogeneity of hepatic arterial blood flow. J Surg Res 1983; 34:17-24.
106. Xu HB, Yan XQ. Diagnosis and therapy for primary hepatic carcinoma: transcatheter inferior phrenic arteriography and chemoembolization. J Tongji Med Univ 1993; 13:186-189.
107. Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998; 9:495-500.
108. Phillips S, Ruttley MS. Bronchial artery embolization: the importance of preliminary thoracic aortography. Clin Radiol 2000; 55:317-319.
109. Won JY, Lee do Y, Lee JT, et al. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2003; 26:136-140.
110. Okino Y, Kiyosue H, Matsumoto S, Takaji R, Yamada Y, Mori H. Hepatocellular carcinoma: prediction of blood supply from right inferior phrenic artery by multiphasic CT. J Comput Assist Tomogr 2003; 27:341-346.
111. Eurvilaichit C, Chuapetcharasopon C. Hepatic arterial collaterals after transcatheter oily chemoembolization of hepatocellular carcinoma. J Med Assoc Thai 2001; 84:75-84.
112. Gokan T, Hashimoto T, Matsui S, Kushihashi T, Nobusawa H, Munechika H. Helical CT demonstration of dilated right inferior phrenic arteries as extrahepatic collateral arteries of hepatocellular carcinomas. J Comput Assist Tomogr 2001; 25:68-73.
113. Soo CS, Chuang VP, Wallace S, Charnsangavej C, Carrasco H. Treatment of hepatic neoplasm through extrahepatic collaterals. Radiology 1983; 147:45-49.